1Cox JD,Stetz J,Pajak TF.Toxcity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys,1995,31:1341-1346.
3Nishuimura Y,Ono K,Tsutsui K,et al.Esophageal cancer treated with radioth erapy:impact of total treatment time and fractionation.Int J Radit Oncol Biol P hys,1994,30:1099-1105.
4Cox JD, Stetz J, Pajak TF. Toxcity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer ( EORTC ). Int J Radiat Oncol Biol Phys, 1995,31:1341-1346.
5Mehta M ,Scrimger R, Maerie R, et al. Anew approach dose escalation in non -smallcell cancer[ J]. Int J Radiat Oncol Biol Phys ,2001,49:23 - 33.
6Evans Es, Koacakz,Zhou SM, et al. Does transforming growth factor - predict for radiation - induced pneumonitis in patients treated for lung cancer [ J ]. Cytokine, 2006,35 ( 3 ) : 186.
7SIBEY G S,JAMICSON T A,MARKS L B,et al.Radio-therapy alone for medically inoperable stage I non-small-cell lung cancer:the Duke experience[J].Int J Radiat Oncol Biol Phys,1998,40:149-154.
8ROBERTSON J M,TEN-HAKEN R K,HAZUKA M B,et al.Doseescalation for non-small cell lung cancer using conformal radiation therapy[J].Int J Radiat Oncol Biol Phys,1997,37:1079-1085.
9MARTEL M K.Advanced radiation treatment planning and delivery approaches for treatment of lung cancer[J].Hematol Oncol Clin North AM,2004,18(1):31-43.
10SLOTMAN B J,ANTONISSE I E,NJO K H,et al.Lim-ited field irradiation in early stage(T1-2N0) non-small cell lung cancer[J].Radiother Oncol,1996,41:41-44.
